slow responder to glp 1 Definitions covered: Regular responder, responder, super responder, Microdosing, splitting doses, top off or turbo dose, supratherapeutic dosing, adjuncts, stacking, cushion, weaning down, slow slow responder to glp 1

C.CeballosG.et al (2010)

Actually, you can recall when the first papers about Kispeptin came out

Not necessarily all of it, but most patients regain a significant portion without lifestyle changes and ongoing monitoring

A meta-analysis was done which indicates that albiglutide is linked to a higher risk of early-stage DR compared to placebo, while showing a reduced risk of late-stage DR compared to insulin (85) Furthermore, the other six FDA-approved GLP-1RAs do not demonstrate a statistically significant association with DR

There is a theoretical increased risk of medullary thyroid cancers, but its not clear how likely this is to actually happen in people, says Fishman, who along with Vash stresses that the link has only ever been studied in animals